8 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... for Treatment & ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment ... algorithm 2018. ... Network (NCCN) guidelines ... #algorithm #hematology